3-138062820-C-T
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PVS1_ModerateBS1_SupportingBS2
The NM_173543.3(DZIP1L):c.2300G>A(p.Trp767*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000263 in 1,613,906 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_173543.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DZIP1L | NM_173543.3 | c.2300G>A | p.Trp767* | stop_gained | Exon 16 of 16 | ENST00000327532.7 | NP_775814.2 | |
DZIP1L | XM_005247198.4 | c.2384G>A | p.Trp795* | stop_gained | Exon 16 of 16 | XP_005247255.1 | ||
DZIP1L | XM_047447642.1 | c.2243G>A | p.Trp748* | stop_gained | Exon 15 of 15 | XP_047303598.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000269 AC: 41AN: 152210Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000263 AC: 66AN: 251170Hom.: 0 AF XY: 0.000250 AC XY: 34AN XY: 135736
GnomAD4 exome AF: 0.000263 AC: 384AN: 1461578Hom.: 2 Cov.: 31 AF XY: 0.000254 AC XY: 185AN XY: 727096
GnomAD4 genome AF: 0.000269 AC: 41AN: 152328Hom.: 0 Cov.: 32 AF XY: 0.000309 AC XY: 23AN XY: 74492
ClinVar
Submissions by phenotype
not provided Uncertain:2
Nonsense variant predicted to result in protein truncation as the last 1 amino acids are lost, although loss-of-function variants have not been reported downstream of this position in the protein; Has not been previously published as pathogenic or benign to our knowledge -
This sequence change creates a premature translational stop signal (p.Trp767*) in the DZIP1L gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 1 amino acid(s) of the DZIP1L protein. This variant is present in population databases (rs200902457, gnomAD 0.09%). This variant has not been reported in the literature in individuals affected with DZIP1L-related conditions. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
DZIP1L-related disorder Uncertain:1
The DZIP1L c.2300G>A variant is predicted to result in premature protein termination (p.Trp767*). Of note, the normal protein terminates at codon 768. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.088% of alleles in individuals of European (Finnish) descent in gnomAD v2.1.1 (as displayed in the table above). However, in gnomAD v4.1.0 (available only on GRCh38), there are two homozygotes of this variant. Although we suspect this variant is benign, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at